Patents by Inventor Nicholas M. Valiante, Jr.

Nicholas M. Valiante, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of small molecule compounds for immunopotentiation
    Patent number: 7893096
    Abstract: The invention provides immunostimulatory compositions comprising a small molecule immuno-poteniator (SMIP) compound and methods of administration thereof. Also provided are methods of administering a SMIP compound in an effective amount to enhance the immune response of a subject to an antigen. Further provided are novel compositions and methods of administering SMIP compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: February 22, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Nicholas M. Valiante, Jr.
  • IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS
    Publication number: 20090311288
    Abstract: The invention proyides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent (s).
    Type: Application
    Filed: March 23, 2007
    Publication date: December 17, 2009
    Applicant: Novartis AG
    Inventors: James Sutton, Feng Xu, Nicholas M. Valiante, JR., Jiong Lan